150 related articles for article (PubMed ID: 12504925)
1. Acetyl-l-carnitine induces muscarinic antinocieption in mice and rats.
Ghelardini C; Galeotti N; Calvani M; Mosconi L; Nicolai R; Bartolini A
Neuropharmacology; 2002 Dec; 43(7):1180-7. PubMed ID: 12504925
[TBL] [Abstract][Full Text] [Related]
2. Prochlorperazine induces central antinociception mediated by the muscarinic system.
Ghelardini C; Galeotti N; Uslenghi C; Grazioli I; Bartolini A
Pharmacol Res; 2004 Sep; 50(3):351-8. PubMed ID: 15225680
[TBL] [Abstract][Full Text] [Related]
3. Acetyl-L-carnitine requires phospholipase C-IP3 pathway activation to induce antinociception.
Galeotti N; Bartolini A; Calvani M; Nicolai R; Ghelardini C
Neuropharmacology; 2004 Aug; 47(2):286-94. PubMed ID: 15223307
[TBL] [Abstract][Full Text] [Related]
4. The antinociceptive effects of centrally administered CDP-choline on acute pain models in rats: the involvement of cholinergic system.
Hamurtekin E; Gurun MS
Brain Res; 2006 Oct; 1117(1):92-100. PubMed ID: 16942753
[TBL] [Abstract][Full Text] [Related]
5. Role of muscarinic receptor subtypes in central antinociception.
Bartolini A; Ghelardini C; Fantetti L; Malcangio M; Malmberg-Aiello P; Giotti A
Br J Pharmacol; 1992 Jan; 105(1):77-82. PubMed ID: 1375858
[TBL] [Abstract][Full Text] [Related]
6. Central cholinergic antinociception induced by 5HT4 agonists: BIMU 1 and BIMU 8.
Ghelardini C; Galeotti N; Casamenti F; Malmberg-Aiello P; Pepeu G; Gualtieri F; Bartolini A
Life Sci; 1996; 58(25):2297-309. PubMed ID: 8649219
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of acetyl-L-carnitine on neuropathic pain and apoptosis: a role for the nicotinic receptor.
Di Cesare Mannelli L; Ghelardini C; Calvani M; Nicolai R; Mosconi L; Toscano A; Pacini A; Bartolini A
J Neurosci Res; 2009 Jan; 87(1):200-7. PubMed ID: 18709658
[TBL] [Abstract][Full Text] [Related]
8. Role of histamine in rodent antinociception.
Malmberg-Aiello P; Lamberti C; Ghelardini C; Giotti A; Bartolini A
Br J Pharmacol; 1994 Apr; 111(4):1269-79. PubMed ID: 8032614
[TBL] [Abstract][Full Text] [Related]
9. Possible involvement of supraspinal opioid and GABA receptors in CDP-choline-induced antinociception in acute pain models in rats.
Hamurtekin E; Bagdas D; Gurun MS
Neurosci Lett; 2007 Jun; 420(2):116-21. PubMed ID: 17531379
[TBL] [Abstract][Full Text] [Related]
10. Loss of muscarinic antinociception by antisense inhibition of M(1) receptors.
Ghelardini C; Galeotti N; Bartolini A
Br J Pharmacol; 2000 Apr; 129(8):1633-40. PubMed ID: 10780968
[TBL] [Abstract][Full Text] [Related]
11. Possible involvement of cholinergic and opioid receptor mechanisms in fluoxetine mediated antinociception response in streptozotocin-induced diabetic mice.
Anjaneyulu M; Chopra K
Eur J Pharmacol; 2006 May; 538(1-3):80-4. PubMed ID: 16650402
[TBL] [Abstract][Full Text] [Related]
12. Antinociception induced by SM 32 depends on a central cholinergic mechanism.
Ghelardini C; Galeotti N; Gualtieri F; Novella Romanelli M; Bartolini A
Pharmacol Res; 1997 Feb; 35(2):141-7. PubMed ID: 9175584
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of the type 2 and 3 inositol 1,4,5-trisphosphate receptors suppresses muscarinic antinociception in mice.
Galeotti N; Quattrone A; Vivoli E; Bartolini A; Ghelardini C
Neuroscience; 2007 Oct; 149(2):409-20. PubMed ID: 17890015
[TBL] [Abstract][Full Text] [Related]
14. Antinociceptive profile of 3-alpha-tropanyl 2-(4-Cl-phenoxy)butyrate (SM-21) [corrected]: a novel analgesic with a presynaptic cholinergic mechanism of action.
Ghelardini C; Galeotti N; Gualtieri F; Bellucci C; Manetti D; Giotti A; Malmberg-Aiello P; Galli A; Bartolini A
J Pharmacol Exp Ther; 1997 Jul; 282(1):430-9. PubMed ID: 9223584
[TBL] [Abstract][Full Text] [Related]
15. Antinociceptive and antiamnesic properties of the presynaptic cholinergic amplifier PG-9.
Ghelardini C; Galeotti N; Gualtieri F; Marchese V; Bellucci C; Bartolini A
J Pharmacol Exp Ther; 1998 Mar; 284(3):806-16. PubMed ID: 9495837
[TBL] [Abstract][Full Text] [Related]
16. Involvement of central cholinergic system in antinociception induced by sumatriptan in mouse.
Ghelardini C; Galeotti N; Nicolodi M; Donaldson S; Sicuteri F; Bartolini A
Int J Clin Pharmacol Res; 1997; 17(2-3):105-9. PubMed ID: 9403365
[TBL] [Abstract][Full Text] [Related]
17. Profile of spinal and supra-spinal antinociception of (-)-linalool.
Peana AT; De Montis MG; Nieddu E; Spano MT; D'Aquila PS; Pippia P
Eur J Pharmacol; 2004 Feb; 485(1-3):165-74. PubMed ID: 14757137
[TBL] [Abstract][Full Text] [Related]
18. 5-HT1A agonists induce central cholinergic antinociception.
Galeotti N; Ghelardini C; Bartolini A
Pharmacol Biochem Behav; 1997 Aug; 57(4):835-41. PubMed ID: 9259013
[TBL] [Abstract][Full Text] [Related]
19. The antinociceptive and sedative effects of carbachol and oxycodone administered into brainstem pontine reticular formation and spinal subarachnoid space in rats.
Ma HC; Dohi S; Wang YF; Ishizawa Y; Yanagidate F
Anesth Analg; 2001 May; 92(5):1307-15. PubMed ID: 11323367
[TBL] [Abstract][Full Text] [Related]
20. Investigation into atropine-induced antinociception.
Ghelardini C; Malmberg-Aiello P; Giotti A; Malcangio M; Bartolini A
Br J Pharmacol; 1990 Sep; 101(1):49-54. PubMed ID: 2282466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
